What is Venus?
Venus specializes in delivering clinically validated and user-friendly medical aesthetic equipment to clinics across the United States and Canada. Their product portfolio encompasses advanced systems for body contouring, multi-treatment applications, radio frequency therapies, and laser hair removal. The company is recognized for its innovative technology, dependable performance, and robust after-sales support, which contribute to both operational efficiency for practices and enhanced patient satisfaction. Venus's commitment to supporting client success through comprehensive onboarding and business growth initiatives further solidifies its market presence.
How much funding has Venus raised?
Venus has raised a total of $143.8M across 9 funding rounds:
Private Equity
$10M
Debt
$20M
Private Equity
$38M
Multiple Rounds
$55.3M
Share Placement
$17M
Debt
$2M
Private Equity
$1.5M
Private Equity (2014): $10M with participation from Longitude Capital
Debt (2015): $20M led by Oxford Finance
Private Equity (2017): $38M supported by HealthQuest Capital and Essex Woodlands
Share Placement (2020): $22.3M featuring SEDCO Capital, HealthQuest Capital, and Essex Woodlands
Debt (2020): $2M backed by PPP
Share Placement (2020): $31M with participation from Lincoln Park Capital Fund , LLC
Share Placement (2021): $17M led by Masters Special Situations, HealthQuest Capital, and Essex Woodlands
Debt (2025): $2M supported by Madryn Asset Management
Private Equity (2026): $1.5M, investors not publicly disclosed
Key Investors in Venus
HealthQuest Capital
HealthQuest Capital is a venture capital firm that invests in healthcare companies, focusing on areas such as medical devices and technology-enabled services.
Essex Woodlands
EW Healthcare Partners (formerly Essex Woodlands) is a prominent private healthcare investment firm with a long history of making growth equity investments in commercial-stage healthcare companies across pharmaceuticals, medical devices, diagnostics, and technology-enabled services.
Longitude Capital
Longitude Capital is a venture capital firm dedicated to investing in the healthcare sector, including biotechnology, medical technology, and health solutions, aiming to scale innovative companies and improve patient care.
What's next for Venus?
The substantial enterprise-level funding and strategic investment indicate Venus is poised for significant expansion and further technological development. This capital infusion will likely fuel advancements in their product line, broaden market reach, and potentially explore new therapeutic applications. The company's trajectory suggests a focus on scaling operations and reinforcing its position as a leader in the medical aesthetics sector, leveraging its established reputation for innovation and client support to drive future growth.
See full Venus company page
